Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Hubert Schrezenmeier | Researchclopedia

Back to researchers

Hubert Schrezenmeier

German Red Cross ORCID

659

Works

25,961

Citations

84

h-index

289

i10-index

Research Topics

Complement system in diseases Hematopoietic Stem Cell Transplantation Blood groups and transfusion

Affiliations

Karlsruhe Institute of Technology2013–2013

Goethe University Frankfurt2003–2010

Leiden University2000–2000

St George's Hospital1999–1999

Universität Hamburg2013–2013

Top Works

The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen,Neal S. Young,et al.

20061,254 citations

Mesenchymal stem cell research

Renal Diseases and Glomerulopathies

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann,Prerna Arora,et al.

20211,041 citations

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Robert A. Brodsky,Neal S. Young,et al.

2007648 citations

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria

Peter Hillmen,Petra Muus,et al.

2007576 citations

Cdc42 Activity Regulates Hematopoietic Stem Cell Aging and Rejuvenation

Maria Carolina Florian,Karin Dörr,et al.

2012571 citations

Aplastic Anemia

Hubert Schrezenmeier

1999502 citations

Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without Cyclosporine

Norbert Frickhofen,J. P. Kaltwasser,et al.

1991422 citations

T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.

Bernhard Fleischer,Hubert Schrezenmeier

1988422 citations

Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study

Jong Wook Lee,Flore Sicre de Fontbrune,et al.

2018389 citations